216
Views
10
CrossRef citations to date
0
Altmetric
Report

Prescription Drug Monitoring Programs: Relationships Among Program Awareness, Use, and State Mandates

Pages 129-133 | Received 19 Jan 2018, Accepted 09 Jun 2018, Published online: 10 Sep 2018

References

  • Jones CM, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55–e63.
  • Centers for Disease Control and Prevention (CDC). Drug overdose deaths hit record numbers in 2014. CDC Web site. www.cdc.gov/media/releases/2015/p1218-drug-overdose.html. Accessed February 27, 2017.
  • Rudd RA, Seth P, David F, Scholl L. Increases in drug and opioid-involved overdose deaths—United States, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65(5051):1445–1452.
  • Martins SS, Storr CL, Zhu H, Chilcoat HD. Correlates of extramedical use of OxyContin® versus other analgesic opioids among the US general population. J Alcohol Drug Depend. 2009;99(1–3):58–67.
  • Kuehn BM. Payers probe ways to help curb risky prescribing. JAMA. 2014;311(11):1097–1098.
  • Substance Abuse and Mental Health Services Administration (SAMHSA). Prescription drug monitoring programs: an assessment of the evidence for best practices. 2017. https://www.samhsa.gov/capt/tools-learning-resources/prescription-drug-monitoring-best-practices. Accessed April 5, 2017.
  • Irvine JM, Hallvik SE, Hildebran C, Marino M, Beran T, Deyo RA. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians. J Pain. 2014;15(7):747–755.
  • Bronson WD. The North Carolina controlled substances reporting system: a valuable tool for combating prescription drug misuse. N C Med J. 2013;74(3):249–253.
  • Haffajee RL, Jena AB, Weiner SG. Mandatory use of prescription drug monitoring programs. JAMA. 2015;313(9):891–892.
  • Deyo RA, Irvine JM, Hallvik SE, et al. Leading a horse to water: facilitating registration and use of a prescription drug monitoring program. Clin J Pain. 2014;31(9):782–787.
  • Rasubala L, Pernapati L, Velasquez X, Burk J, Ren YF. Impact of a mandatory prescription drug monitoring program on prescription of opioid analgesics by dentists. PLoS One. 2015;10(8):e0135957.
  • Rutkow L, Chang HY, Daubresse M, Webster DW, Stuart EA, Alexander GC. Effect of Florida's prescription drug monitoring program and pill mill laws on opioid prescribing and use. JAMA Intern Med. 2015;175(10):1642–1649.
  • Feldman L, Williams KS, Coates J, Knox M. Awareness and utilization of a prescription monitoring program among physicians. J Pain Palliat Care Pharmacother. 2011;25(4):313–317.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.